$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating activities    
Net loss $ (208,843) $ (59,422)
Adjustments to reconcile net loss to cash used for operating activities:    
Depreciation 67,495 64,005
Amortization of intangible and other assets 665 1,251
Amortization of debt issue costs 2,590 1,328
Interest accrued on NCM screen advertising advances (5,835)  
Amortization of NCM screen advertising advances and deferred revenues (7,934) (7,852)
Amortization of accumulated losses for amended swap agreements 1,124  
Impairment of long-lived assets   16,619
Share based awards compensation expense 4,668 4,111
Loss on disposal of assets and other 4,505 1,905
Loss on extinguishment of debt 2,603  
Non-cash rent expense 128 (591)
Equity in (income) loss of affiliates 6,806 (8,486)
Deferred income tax expenses (18,070) 15,364
Distributions from equity investees 156 16,606
Changes in assets and liabilities and other 14,193 (66,290)
Net cash used for operating activities (124,079) (15,561)
Investing activities    
Additions to theatre properties and equipment (17,680) (34,143)
Proceeds from sale of theatre properties and equipment and other 21 55
Investment in joint ventures and other, net   (50)
Net cash used for investing activities (17,659) (34,138)
Financing activities    
Dividends paid to stockholders   (42,311)
Payroll taxes paid as a result of stock withholdings (8) (2,691)
Proceeds from revolving line of credit   98,800
Proceeds from issuance of senior notes 405,000  
Proceeds from other borrowings 9,012  
Redemption of senior notes (400,000)  
Repayments of long-term debt (1,999) (1,649)
Payment of debt issue costs (5,980)  
Fees paid related to debt refinancing (1,435)  
Payments on finance leases [1] (3,742) (3,789)
Other   (392)
Net cash provided by financing activities 848 47,968
Effect of exchange rate changes on cash and cash equivalents (1,620) (7,183)
Decrease in cash and cash equivalents (142,510) (8,914)
Cash and cash equivalents:    
Beginning of period 655,338 488,313
End of period 512,828 479,399
Adjustments to reconcile net loss to cash used for operating activities:    
Interest accrued on NCM screen advertising advances $ 5,835 $ 5,891
[1] As discussed above at Lease Deferrals and Abatements, the Company negotiated certain lease amendments to defer and/or abate contractual payments as a result of the COVID-19 pandemic and temporary closure of theatres.  In accordance with FASB Staff guidance, the Company did not recalculate lease liabilities and right of use assets for amendments that did not result in a substantial increase in the rights of the lessor or the obligations of the lessee.  Contractual payment amounts for the three months ended March 31, 2021 above are prior to the impact of deferred or abated rent amounts.